Michael Jacoby, MD
Neurology · Des Moines, IANPI 1346354198
Payments from drug & device makers
Across 425 payments — averaging $571.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$137K
- Lilly USA, LLC$31K
- Amgen$30K
- Pfizer$24K
- Lundbeck LLC$10K
- Biohaven Pharmaceuticals, Inc.$7K
- plus $3K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 209 | $136,546 |
| Lilly USA, LLC | 39 | $31,174 |
| Amgen | 37 | $30,034 |
| Pfizer | 20 | $24,497 |
| Lundbeck LLC | 17 | $9,888 |
| Biohaven Pharmaceuticals, Inc. | 7 | $7,375 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $1,177 |
| Teva Pharmaceuticals USA, Inc. | 30 | $821 |
| Novartis | 14 | $259 |
| Genentech USA, Inc. | 2 | $150 |
| Sunovion Pharmaceuticals Inc. | 5 | $142 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $123 |
| E.r. Squibb & Sons, L.L.C. | 1 | $104 |
| Supernus Pharmaceuticals, Inc. | 5 | $87 |
| EMD Serono, Inc. | 3 | $79 |
| UCB, Inc. | 4 | $75 |
| Biogen | 4 | $54 |
| Argenx US, Inc. | 2 | $53 |
| TG Therapeutics, Inc. | 3 | $47 |
| Eisai Inc. | 2 | $40 |
| SK Life Science, Inc. | 1 | $38 |
| Adamas Pharmaceuticals, Inc. | 2 | $34 |
| CSL Behring | 1 | $32 |
| Alnylam Pharmaceuticals Inc. | 2 | $32 |
| GE HealthCare | 1 | $29 |
| Promius Pharma LLC | 1 | $22 |
| Merz North America, Inc. | 1 | $18 |
| AstraZeneca | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Tanabe Pharma America, Inc. | 1 | $16 |
| Upsher-smith Laboratories LLC | 1 | $16 |
| MDD US Operations, LLC | 1 | $14 |
How this compares
$243,007 in reported general payments places this provider in the 95th percentile of 132 neurology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Des Moines
- Bruce HughesDes Moines$2.1M
- Lynn RankinDes Moines$232K
- Wendy ZadehDes Moines$134K
- Paul BabikianDes Moines$107K
- Mark PuricelliDes Moines$45K
- Keith KohoutDes Moines$36K
- Erik ArnesonDes Moines$10K
- John WrightDes Moines$9K
- Lynn StruckDes Moines$6K
- Irving WolfeDes Moines$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.